| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 0.00% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 0.00% | |
| Healthcare | 100.00% |
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 56.66 | 0.00 (0.00%) | 41.44 - 61.53 | 68.0 thousand (Above Avg) |
Market data as of 3:59PM 06/19/13. Quotes are delayed by at least 15 min.
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.
| Open | 57.31 |
|---|---|
| Previous Close | 56.66 |
| Day's Range | 56.66 - 57.67 |
| Avg Volume (10 Day) | 54.2K |
| Total Assets | $347.86M |
| Expense Ratio | 0.61% |
| Yield (Trailing 12 Mo.) | 0.00% |
| Fund Inception | 06/19/2006 |
| Timeframe | FBT | S&P 500 | Health |
|---|---|---|---|
| 1 Month | 2.70% | 2.34% | 2.69% |
| 3 Month | 16.41% | 8.22% | 11.87% |
| Year-to-Date | 28.03% | 15.37% | 21.07% |
| 1 Year | 38.57% | 27.28% | 35.83% |
| 3 Year | 22.86% | 16.87% | 21.93% |
| 5 Year | 20.49% | 5.43% | 13.47% |
| 10 Year | -- | 7.58% | 8.36% |
| Since Inception | 17.03% | 10.42% | -- |
| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 0.00% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 0.00% | |
| Healthcare | 100.00% |
| Utilities | 0.00% | |
|---|---|---|
| Communication Services | 0.00% | |
| Energy | 0.00% | |
| Industrials | 0.00% | |
| Technology | 0.00% |
| Valuation | FBT | Category Range |
|---|---|---|
| Price/Earnings | 27.26 | |
| Price/Book | 4.58 | |
| Price/Sales | 4.98 | |
| Price/Cash Flow | 20.55 | |
| Dividend Yield | 0.17 | |
| LT Earnings | 17.32 | |
| Historical Earnings | 21.49 | |
| Sales Growth | 9.99 | |
| Cash-Flow Growth | -6.6 | |
| Book-Value Growth | -4.9 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
![]() | ![]() | ![]() |

| Rating | vs Category | |
|---|---|---|
| Overall | ![]() ![]() ![]() | |
| Risk | High | |
| Return | Avg |
| Beta | 0.97 |
|---|---|
| Standard Deviation | 23.04 |
| Alpha | 9.99 |
| Sharpe Ratio | 1.01 |
| Mean | 25.93 |
| R-Squared | 42.36 |
| Pretax Return | 22.86% |
|---|---|
| Tax-adjusted Return | 22.86% |
| Tax Cost Ratio | 0.00% |
| Potential Cap Gains | 3.63% |